Revolution Medicines, Inc. (RVMD) Tops Q1 EPS by 5c

Revolution Medicines, Inc. (NASDAQ: RVMD) reported Q1 EPS of ($0.70), $0.05 better than the analyst estimate of ($0.75).

For earnings history and earnings-related data on Revolution Medicines, Inc. (RVMD) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• ICICI Bank (ICICIBC:IN) (IBN) PT Raised to INR2,000 at Goldman Sachs
• JPMorgan Starts Bechtle AG (BC8:GR) (BECTY) at Neutral